Griffith D. Parks - Publications

Affiliations: 
Wake Forest University School of Medicine, Winston-Salem, NC, United States 
Area:
Microbiology Biology

72 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Fox CR, Kedarinath K, Neal CJ, Sheiber J, Kolanthai E, Kumar U, Drake C, Seal S, Parks GD. Broad-Spectrum, Potent, and Durable Ceria Nanoparticles Inactivate RNA Virus Infectivity by Targeting Virion Surfaces and Disrupting Virus-Receptor Interactions. Molecules (Basel, Switzerland). 28. PMID 37446852 DOI: 10.3390/molecules28135190  0.318
2023 Kedarinath K, Shiffer EM, Parks GD. DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus. Anti-Cancer Drugs. PMID 37227036 DOI: 10.1097/CAD.0000000000001525  0.459
2022 Kumar U, Fox CR, Kolanthai E, Neal CJ, Kedarinath K, Fu Y, Marcelo E, Babu B, Parks GD, Seal S. Potent Inactivation of Human Respiratory Viruses Including SARS-CoV-2 by a Photoactivated Self-Cleaning Regenerative Antiviral Coating. Acs Applied Materials & Interfaces. PMID 36004755 DOI: 10.1021/acsami.2c11653  0.308
2022 Kedarinath K, Parks GD. Differential In Vitro Growth and Cell Killing of Cancer versus Benign Prostate Cells by Oncolytic Parainfluenza Virus. Pathogens (Basel, Switzerland). 11. PMID 35631014 DOI: 10.3390/pathogens11050493  0.425
2021 Varudkar N, Oyer JL, Copik A, Parks GD. Oncolytic parainfluenza virus combines with NK cells to mediate killing of infected and non-infected lung cancer cells within 3D spheroids: role of type I and type III interferon signaling. Journal For Immunotherapy of Cancer. 9. PMID 34172515 DOI: 10.1136/jitc-2021-002373  0.339
2020 Cruz MA, Parks GD. Enhancement of Infectivity of Insect Cell-Derived La Crosse Virus by Human Serum. Virus Research. 198228. PMID 33188797 DOI: 10.1016/j.virusres.2020.198228  0.306
2020 Cruz MA, Parks GD. La Crosse Virus Infection of Human Keratinocytes Leads to Interferon-Dependent Apoptosis of Bystander Non-Infected Cells In Vitro. Viruses. 12. PMID 32106552 DOI: 10.3390/v12030253  0.38
2019 Fox CR, Parks GD. Histone Deacetylase Inhibitors Enhance Cell Killing and Block Interferon-Beta Synthesis Elicited by Infection with an Oncolytic Parainfluenza Virus. Viruses. 11. PMID 31083335 DOI: 10.3390/v11050431  0.414
2018 Mazar J, Li Y, Rosado A, Phelan P, Kedarinath K, Parks GD, Alexander KA, Westmoreland TJ. Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24. Plos One. 13: e0200358. PMID 30044847 DOI: 10.1371/Journal.Pone.0200358  0.388
2018 Fox CR, Parks GD. Parainfluenza Virus Infection Sensitizes Cancer Cells to DNA Damaging Agents: Implications for Oncolytic Virus Therapy. Journal of Virology. PMID 29343567 DOI: 10.1128/JVI.01948-17  0.385
2016 Holbrook BC, D'Agostino RB, Parks GD, Alexander-Miller MA. Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model. Vaccine. PMID 27516064 DOI: 10.1016/J.Vaccine.2016.08.010  0.352
2016 Li Y, Johnson JB, Parks GD. Parainfluenza virus 5 upregulates CD55 expression to produce virions with enhanced resistance to complement-mediated neutralization. Virology. 497: 305-313. PMID 27505156 DOI: 10.1016/J.Virol.2016.07.030  0.383
2016 Holbrook BC, Kim JR, Blevins LK, Jorgensen MJ, Kock ND, D'Agostino RB, Aycock ST, Hadimani MB, King SB, Parks GD, Alexander-Miller MA. A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model. Journal of Immunology (Baltimore, Md. : 1950). PMID 27279374 DOI: 10.4049/Jimmunol.1600497  0.339
2015 Holbrook BC, Hayward SL, Blevins LK, Kock N, Aycock T, Parks GD, Alexander-Miller MA. Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection. Virology. 476: 124-33. PMID 25543963 DOI: 10.1016/J.Virol.2014.12.007  0.361
2015 Johnson JB, Borisevich V, Rockx B, Parks GD. A novel factor I activity in Nipah virus inhibits human complement pathways through cleavage of C3b. Journal of Virology. 89: 989-98. PMID 25355897 DOI: 10.1128/Jvi.02427-14  0.387
2014 Mayer AE, Parks GD. An AGM model for changes in complement during pregnancy: neutralization of influenza virus by serum is diminished in late third trimester. Plos One. 9: e112749. PMID 25409303 DOI: 10.1371/Journal.Pone.0112749  0.395
2014 Blevins LK, Wren JT, Holbrook BC, Hayward SL, Swords WE, Parks GD, Alexander-Miller MA. Coinfection with Streptococcus pneumoniae negatively modulates the size and composition of the ongoing influenza-specific CD8⁺ T cell response. Journal of Immunology (Baltimore, Md. : 1950). 193: 5076-87. PMID 25311807 DOI: 10.4049/Jimmunol.1400529  0.449
2014 Mayer AE, Johnson JB, Parks GD. The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement. Virology. 460: 23-33. PMID 25010267 DOI: 10.1016/J.Virol.2014.05.004  0.439
2014 Khalil SM, Tonkin DR, Snead AT, Parks GD, Johnston RE, White LJ. An alphavirus-based adjuvant enhances serum and mucosal antibodies, T cells, and protective immunity to influenza virus in neonatal mice. Journal of Virology. 88: 9182-96. PMID 24899195 DOI: 10.1128/Jvi.00327-14  0.372
2014 Ganguly T, Johnson JB, Kock ND, Parks GD, Deora R. The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing. Cellular Microbiology. 16: 1105-18. PMID 24438122 DOI: 10.1111/Cmi.12264  0.308
2013 Parks GD, Alexander-Miller MA. Paramyxovirus activation and inhibition of innate immune responses. Journal of Molecular Biology. 425: 4872-92. PMID 24056173 DOI: 10.1016/J.Jmb.2013.09.015  0.459
2013 Johnson JB, Schmitt AP, Parks GD. Point mutations in the paramyxovirus F protein that enhance fusion activity shift the mechanism of complement-mediated virus neutralization. Journal of Virology. 87: 9250-9. PMID 23785199 DOI: 10.1128/Jvi.01111-13  0.438
2012 Biswas M, Johnson JB, Kumar SR, Parks GD, Elankumarana S, Subbiah E. Incorporation of host complement regulatory proteins into Newcastle disease virus enhances complement evasion. Journal of Virology. 86: 12708-16. PMID 22973037 DOI: 10.1128/Jvi.00886-12  0.388
2012 Briggs CM, Mayer AE, Parks GD. Mumps virus inhibits migration of primary human macrophages toward a chemokine gradient through a TNF-alpha dependent mechanism. Virology. 433: 245-52. PMID 22935226 DOI: 10.1016/J.Virol.2012.08.017  0.43
2012 Johnson JB, Lyles DS, Alexander-Miller MA, Parks GD. Virion-associated complement regulator CD55 is more potent than CD46 in mediating resistance of mumps virus and vesicular stomatitis virus to neutralization Journal of Virology. 86: 9929-9940. PMID 22761385 DOI: 10.1128/Jvi.01154-12  0.353
2011 Clark KM, Johnson JB, Kock ND, Mizel SB, Parks GD. Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge. Virology. 419: 97-106. PMID 21885079 DOI: 10.1016/J.Virol.2011.08.005  0.4
2011 Johnson JB, Aguilar HC, Lee B, Parks GD. Interactions of human complement with virus particles containing the Nipah virus glycoproteins. Journal of Virology. 85: 5940-8. PMID 21450814 DOI: 10.1128/Jvi.00193-11  0.409
2011 Briggs CM, Holder RC, Reid SD, Parks GD. Activation of human macrophages by bacterial components relieves the restriction on replication of an interferon-inducing parainfluenza virus 5 (PIV5) P/V mutant. Microbes and Infection / Institut Pasteur. 13: 359-68. PMID 21185944 DOI: 10.1016/J.Micinf.2010.12.005  0.524
2010 Palmer EM, Holbrook BC, Arimilli S, Parks GD, Alexander-Miller MA. IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment. Virology. 404: 225-30. PMID 20627346 DOI: 10.1016/J.Virol.2010.05.004  0.384
2010 Manuse MJ, Briggs CM, Parks GD. Replication-independent activation of human plasmacytoid dendritic cells by the paramyxovirus SV5 Requires TLR7 and autophagy pathways. Virology. 405: 383-9. PMID 20605567 DOI: 10.1016/J.Virol.2010.06.023  0.492
2010 Arimilli S, Sharma SK, Yammani R, Reid SD, Parks GD, Alexander-Miller MA. Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1. Journal of Leukocyte Biology. 87: 977-88. PMID 20103768 DOI: 10.1189/Jlb.0809575  0.351
2010 Manuse MJ, Parks GD. TLR3-dependent upregulation of RIG-I leads to enhanced cytokine production from cells infected with the parainfluenza virus SV5. Virology. 397: 231-41. PMID 19948350 DOI: 10.1016/J.Virol.2009.11.014  0.458
2010 Johnson JB, Lyles DS, Parks GD. Complement evasion by vesicular stomatitis virus involves recruitment of host complement regulatory proteins Molecular Immunology. 47: 2239-2239. DOI: 10.1016/J.Molimm.2010.05.129  0.404
2009 Manuse MJ, Parks GD. Role for the paramyxovirus genomic promoter in limiting host cell antiviral responses and cell killing. Journal of Virology. 83: 9057-67. PMID 19587032 DOI: 10.1128/Jvi.01055-09  0.512
2009 Johnson JB, Grant K, Parks GD. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization. Journal of Virology. 83: 7602-11. PMID 19457998 DOI: 10.1128/Jvi.00713-09  0.404
2008 Arimilli S, Johnson JB, Clark KM, Graff AH, Alexander-Miller MA, Mizel SB, Parks GD. Engineered expression of the TLR5 ligand flagellin enhances paramyxovirus activation of human dendritic cell function. Journal of Virology. 82: 10975-85. PMID 18787007 DOI: 10.1128/Jvi.01288-08  0.445
2008 Gainey MD, Manuse MJ, Parks GD. A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon. Journal of Virology. 82: 9369-80. PMID 18667520 DOI: 10.1128/Jvi.01054-08  0.509
2008 Capraro GA, Johnson JB, Kock ND, Parks GD. Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5. Virology. 376: 416-28. PMID 18456301 DOI: 10.1016/J.Virol.2008.03.034  0.786
2008 Johnson JB, Capraro GA, Parks GD. Differential mechanisms of complement-mediated neutralization of the closely related paramyxoviruses simian virus 5 and mumps virus. Virology. 376: 112-23. PMID 18440578 DOI: 10.1016/J.Virol.2008.03.022  0.75
2008 Gainey MD, Dillon PJ, Clark KM, Manuse MJ, Parks GD. Paramyxovirus-induced shutoff of host and viral protein synthesis: role of the P and V proteins in limiting PKR activation. Journal of Virology. 82: 828-39. PMID 17977969 DOI: 10.1128/Jvi.02023-07  0.541
2007 Dillon PJ, Parks GD. Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. Journal of Virology. 81: 11116-27. PMID 17686837 DOI: 10.1128/Jvi.01360-07  0.529
2007 Arimilli S, Johnson JB, Alexander-Miller MA, Parks GD. TLR-4 and -6 agonists reverse apoptosis and promote maturation of simian virus 5-infected human dendritic cells through NFkB-dependent pathways. Virology. 365: 144-56. PMID 17459446 DOI: 10.1016/J.Virol.2007.02.035  0.415
2007 Pejawar-Gaddy S, Gitiban-Vaghefi N, Parks GD, Alexander-Miller MA. Distinct pathways for signaling maturation in macrophages and dendritic cells after infection with paramyxovirus simian virus 5. Viral Immunology. 20: 76-87. PMID 17425423 DOI: 10.1089/Vim.2006.0070  0.431
2007 Connor JH, McKenzie MO, Parks GD, Lyles DS. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses Virology. 362: 109-119. PMID 17258257 DOI: 10.1016/J.Virol.2006.12.026  0.455
2006 Dillon PJ, Wansley EK, Young VA, Alexander-Miller MA, Parks GD. Exchange of P/V genes between two non-cytopathic simian virus 5 variants results in a recombinant virus that kills cells through death pathways that are sensitive to caspase inhibitors. The Journal of General Virology. 87: 3643-8. PMID 17098980 DOI: 10.1099/Vir.0.82242-0  0.787
2006 Arimilli S, Alexander-Miller MA, Parks GD. A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function. Journal of Virology. 80: 3416-27. PMID 16537609 DOI: 10.1128/Jvi.80.7.3416-3427.2006  0.553
2006 Young VA, Dillon PJ, Parks GD. Variants of the paramyxovirus Simian virus 5 with accelerated or delayed viral gene expression activate proinflammatory cytokine synthesis. Virology. 350: 90-102. PMID 16480754 DOI: 10.1016/J.Virol.2006.01.006  0.586
2005 Pejawar SS, Parks GD, Alexander-Miller MA. Abortive versus productive viral infection of dendritic cells with a paramyxovirus results in differential upregulation of select costimulatory molecules. Journal of Virology. 79: 7544-57. PMID 15919909 DOI: 10.1128/Jvi.79.12.7544-7557.2005  0.434
2005 Wansley EK, Dillon PJ, Gainey MD, Tam J, Cramer SD, Parks GD. Growth sensitivity of a recombinant simian virus 5 P/V mutant to type I interferon differs between tumor cell lines and normal primary cells. Virology. 335: 131-44. PMID 15823612 DOI: 10.1016/J.Virol.2005.02.004  0.797
2005 Gray PM, Arimilli S, Palmer EM, Parks GD, Alexander-Miller MA. Altered function in CD8+ T cells following paramyxovirus infection of the respiratory tract. Journal of Virology. 79: 3339-49. PMID 15731228 DOI: 10.1128/Jvi.79.6.3339-3349.2005  0.417
2004 Gray PM, Parks GD, Alexander-Miller MA. Modulation of CD8+ T cell avidity by increasing the turnover of viral antigen during infection. Cellular Immunology. 231: 14-9. PMID 15919365 DOI: 10.1016/J.Cellimm.2004.12.002  0.462
2003 Wansley EK, Grayson JM, Parks GD. Apoptosis induction and interferon signaling but not IFN-beta promoter induction by an SV5 P/V mutant are rescued by coinfection with wild-type SV5. Virology. 316: 41-54. PMID 14599789 DOI: 10.1016/S0042-6822(03)00584-1  0.793
2003 Young VA, Parks GD. Simian virus 5 is a poor inducer of chemokine secretion from human lung epithelial cells: identification of viral mutants that activate interleukin-8 secretion by distinct mechanisms. Journal of Virology. 77: 7124-30. PMID 12768033 DOI: 10.1128/Jvi.77.12.7124-7130.2003  0.481
2003 Keller MA, Parks GD. Positive- and negative-acting signals combine to determine differential RNA replication from the paramyxovirus simian virus 5 genomic and antigenomic promoters. Virology. 306: 347-58. PMID 12642107 DOI: 10.1016/S0042-6822(02)00071-5  0.335
2003 Gray PM, Parks GD, Alexander-Miller MA. High avidity CD8+ T cells are the initial population elicited following viral infection of the respiratory tract. Journal of Immunology (Baltimore, Md. : 1950). 170: 174-81. PMID 12496398 DOI: 10.4049/Jimmunol.170.1.174  0.403
2002 Wansley EK, Parks GD. Naturally occurring substitutions in the P/V gene convert the noncytopathic paramyxovirus simian virus 5 into a virus that induces alpha/beta interferon synthesis and cell death. Journal of Virology. 76: 10109-21. PMID 12239285 DOI: 10.1128/Jvi.76.20.10109-10121.2002  0.799
2002 Parks GD, Alexander-Miller MA. High avidity cytotoxic T lymphocytes to a foreign antigen are efficiently activated following immunization with a recombinant paramyxovirus, simian virus 5. The Journal of General Virology. 83: 1167-72. PMID 11961272 DOI: 10.1099/0022-1317-83-5-1167  0.355
2002 Parks GD, Young VA, Koumenis C, Wansley EK, Layer JL, Cooke KM. Controlled cell killing by a recombinant nonsegmented negative-strand RNA virus. Virology. 293: 192-203. PMID 11853412 DOI: 10.1006/Viro.2001.1298  0.771
2001 Gray PM, Parks GD, Alexander-Miller MA. A novel CD8-independent high-avidity cytotoxic T-lymphocyte response directed against an epitope in the phosphoprotein of the paramyxovirus simian virus 5 Journal of Virology. 75: 10065-10072. PMID 11581375 DOI: 10.1128/Jvi.75.21.10065-10072.2001  0.419
2001 Parisien JP, Lau JF, Rodriguez JJ, Sullivan BM, Moscona A, Parks GD, Lamb RA, Horvath CM. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology. 283: 230-9. PMID 11336548 DOI: 10.1006/Viro.2001.0856  0.439
2001 Keller MA, Murphy SK, Parks GD. RNA replication from the simian virus 5 antigenomic promoter requires three sequence-dependent elements separated by sequence-independent spacer regions. Journal of Virology. 75: 3993-8. PMID 11264390 DOI: 10.1128/Jvi.75.8.3993-3998.2001  0.354
2001 Parks GD, Ward KR, Rassa JC. Increased readthrough transcription across the simian virus 5 M-F gene junction leads to growth defects and a global inhibition of viral mRNA synthesis. Journal of Virology. 75: 2213-23. PMID 11160725 DOI: 10.1128/Jvi.75.5.2213-2223.2001  0.788
2000 Rassa JC, Wilson GM, Brewer GA, Parks GD. Spacing constraints on reinitiation of paramyxovirus transcription: the gene end U tract acts as a spacer to separate gene end from gene start sites. Virology. 274: 438-49. PMID 10964786 DOI: 10.1006/Viro.2000.0494  0.762
1999 Rassa JC, Parks GD. Highly diverse intergenic regions of the paramyxovirus simian virus 5 cooperate with the gene end U tract in viral transcription termination and can influence reinitiation at a downstream gene. Journal of Virology. 73: 3904-12. PMID 10196285 DOI: 10.1128/Jvi.73.5.3904-3912.1999  0.765
1999 Murphy SK, Parks GD. RNA replication for the paramyxovirus simian virus 5 requires an internal repeated (CGNNNN) sequence motif Journal of Virology. 73: 805-809. PMID 9847393 DOI: 10.1128/Jvi.73.1.805-809.1999  0.371
1998 Rassa JC, Parks GD. Molecular basis for naturally occurring elevated readthrough transcription across the M-F junction of the paramyxovirus SV5. Virology. 247: 274-86. PMID 9705920 DOI: 10.1006/Viro.1998.9266  0.767
1998 Murphy SK, Ito Y, Parks GD. A functional antigenomic promoter for the paramyxovirus simian virus 5 requires proper spacing between an essential internal segment and the 3' terminus Journal of Virology. 72: 10-19. PMID 9420195 DOI: 10.1128/Jvi.72.1.10-19.1998  0.38
1997 Murphy SK, Parks GD. Genome nucleotide lengths that are divisible by six are not essential but enhance replication of defective interfering RNAs of the paramyxovirus simian virus 5 Virology. 232: 145-157. PMID 9185598 DOI: 10.1006/Viro.1997.8530  0.317
1996 Parks GD. Differential effects of changes in the length of a signal/anchor domain on membrane insertion, subunit assembly, and intracellular transport of a type II integral membrane protein Journal of Biological Chemistry. 271: 7187-7195. PMID 8636156 DOI: 10.1074/Jbc.271.12.7187  0.321
1995 Parks GD, Pohlmann S. Structural requirements in the membrane-spanning domain of the paramyxovirus HN protein for the formation of a stable tetramer Virology. 213: 263-270. PMID 7483273 DOI: 10.1006/Viro.1995.1569  0.325
1994 Parks GD. Mapping of a region of the paramyxovirus L protein required for the formation of a stable complex with the viral phosphoprotein P Journal of Virology. 68: 4862-4872. PMID 8035485 DOI: 10.1128/Jvi.68.8.4862-4872.1994  0.326
1986 Parks GD, Duke GM, Palmenberg AC. Encephalomyocarditis virus 3C protease: Efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region Journal of Virology. 60: 376-384. PMID 3021972 DOI: 10.1128/Jvi.60.2.376-384.1986  0.305
Show low-probability matches.